![David Fisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Fisher
Direktor/Vorstandsmitglied bei
Australian Biomedical Fund No. 1 Ltd.
Profil
David M.
Fisher is currently a Director at Australian Biotechnology & Healthcare Fund No.
3 Ltd., Australian Biomedical Fund No.
1 Ltd., and Australian Biomedical Fund No.
2 Ltd. He is a Venture Partner at Brandon Capital Partners Pty Ltd. since 2006 and a Member of AusBiotech Ltd. Formerly, Dr. Fisher was Chief Executive Officer at Arana Therapeutics Ltd., GI Therapies Pty Ltd., and Cephalon LLC.
He served as Non-Executive Director at Aeris Environmental Ltd. from 2013 to 2014, and also held Non-Executive Director roles at Signostics Ltd. and Director at Global Kinetics Pty Ltd. From 2012 to 2024, he was an Independent Non-Executive Director at Nanosonics Ltd. Education includes undergraduate and doctorate degrees from The University of Sydney.
Aktive Positionen von David Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
Australian Biomedical Fund No. 1 Ltd.
 Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direktor/Vorstandsmitglied | - |
Australian Biomedical Fund No. 2 Ltd.
 Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direktor/Vorstandsmitglied | - |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
 Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Direktor/Vorstandsmitglied | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Corporate Officer/Principal | - |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01.09.2006 |
Ehemalige bekannte Positionen von David Fisher
| Unternehmen | Position | Ende |
|---|---|---|
| NANOSONICS LIMITED | Direktor/Vorstandsmitglied | 12.11.2024 |
| AERIS ENVIRONMENTAL LTD | Präsident | 29.03.2013 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Vorstandsvorsitzender | - |
GI Therapies Pty Ltd.
 GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Vorstandsvorsitzender | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von David Fisher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Nanosonics Ltd.
 Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Arana Therapeutics Ltd.
 Arana Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals; researches medical diagnostic products | Health Technology |
Aeris Environmental Ltd.
 Aeris Environmental Ltd. Household/Personal CareConsumer Non-Durables Manufactures and distributes cleaning products | Consumer Non-Durables |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Biotechnology & Healthcare Fund No. 3 Ltd.
Australian Biotechnology & Healthcare Fund No. 3 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Australian Biomedical Fund No. 2 Ltd.
Australian Biomedical Fund No. 2 Ltd. Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Signostics Ltd.
 Signostics Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for neurology and provides related services | Health Technology |
GI Therapies Pty Ltd.
GI Therapies Pty Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices for the treatment of chronic constipation | Health Technology |
